Oxford BioMedica SWOT Analysis, USP & Competitors

Posted in Pharmaceuticals and Healthcare, Total Reads: 1242
Advertisements

SWOT Analysis of Oxford BioMedica with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis

Oxford BioMedica

Parent Company

Oxford BioMedica

Category

Biopharmaceuticals

Sector

Healthcare

Tagline/ Slogan

Discover.Realise

USP

Oxford BioMedica designs, develops and manufactures unique gene-based medicines.

STP

Segment

The development of gene-based medicines and therapeutic vaccines.

Target Group

Healthcare professionals, doctors & hospitals

Positioning

Oxford BioMedica targets unmet global healthcare needs through gene and cell therapy.

SWOT Analysis

Strengths

1. Has exceptional core in-house expertise in genetic engineering techniques and cancer immunology
2. OXB conducts collaborative research with partners including Sanofi, Pfizer, Novartis, GlaxoSmithKline, etc.
3. Unique, high value business model.

4. Strong focus on research and innovation

5. Small yet expert team of employees

Weaknesses

1. Largely dependent on UK’s market for revenue generation
2. Limited presence in emerging markets

Opportunities

1. Partner with other pharmaceuticals for research and expansion purposes.
2. The biopharmaceutical industry has a huge potential for growth.

Threats

1. Stringent drug development guidelines
2. Strict government policies relating to the pharmaceuticals industry
3. Ethical issues related to testing

Competition

Competitors

1. DiaMedica
2. Sanomune



Advertisements



Looking for More Brands? Search BrandGuide

Edit the Brand or Add a New One : Contribute to BrandGuide

The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only.
Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.